
Trudo Lemmens
78 Queen's Park
Education
Overview
Trudo Lemmens, CandJur, LicJur (KULeuven), LLM bioethics, DCL (McGill), is Professor and Scholl Chair in Health Law and Policy. He is cross appointed to the Dalla Lana School of Public Health, the Temerty Faculty of Medicine, and the Joint Centre for Bioethics. His research focuses on the interaction between law, governance tools, and ethical norms and values in the context of health care, biomedical research, pharmaceutical and other health product development, and knowledge production.
Since joining the Faculty of Law, professor Lemmens has been a member of the School of Social Science of the Institute for Advanced Study in Princeton, a visiting fellow of the Royal Flemish Academy of Belgium for Science and the Arts, a visiting professor at the K.U.Leuven (Belgium), the Pontificia Universidad Javeriana (Bogota, Colombia), the University Torcuato di Tella (Buenos Aires, Argentina), and the University of Otago (Dunedin, New Zealand) ; a Plumer Visiting Fellow at Oxford’s St. Anne’s College, and an academic visitor at the Faculty of Law and the HeLEX Center for Health, Law and Emerging Technologies of the University of Oxford.
Professor Lemmens’ publications include the co-authored books Medical Law in Canada and Reading the Future? Legal and Ethical Challenges of Predictive Genetic Testing, the co-edited volumes Regulating Creation: The Law, Policy and Ethics of Assisted Human Reproduction, and Law and Ethics in Biomedical Research: Regulation, Conflict of Interest, and Liability, as well as numerous chapters and articles in national and international law, policy, science, medicine and bioethics journals. He has been consulted widely by national and international organizations and has presented in the area of his expertise before a variety of parliamentary committees. He is currently a member of the Advisory Committee on Health Research of the Pan American Health Organization. In the last five years, he was a member of two expert panels of the Council of Canadian Academies: one on access to health data, the other on advance requests and medical assistance in dying.
Areas of Interest
- Health Law & Policy
- Human Rights Law
- Innovation Law & Technology
- Constitutional Law & Theory
Teaching
Fall Session
Winter Session
Full Year Session
Selected Publications
Kevin Bardosh, et al. (2022). COVID-19 vaccine boosters for young adults: a risk benefit assessment and ethical analysis of mandate policies at universities. (2022) Journal of Medical Ethics online: https://jme.bmj.com/content/early/2022/12/05/jme-2022-108449
Kevin Bardosh, et al. "The Unintended Consequences of COVID-19 Vaccine Policy: Why Mandates, Passports and Restrictions May Cause More Harm Than Good" (2022) 7 e008684 BMJ Global Health doi:10.1136/bmjgh-2022-008684
Sonu Gaind, Trudo Lemmens, Ramona Coelho, John Maher, “Canada's Medically Administered Death (MAD) Expansion for Mental Illness: Targeting the Most Vulnerable” (2022) 70(4) World Medical Journal 72-82.
Ramona Coelho, Sonu Gaind, Trudo Lemmens, John Maher, “Normalizing Death as "Treatment" in Canada: Whose Suicides do we Prevent, and whose do we Abet?” (2022) 70(3) World Medical Journal 27-35 (online: https://www.wma.net/wp-content/uploads/2022/11/WMJ_2022_03_final-1.pdf)
Trudo Lemmens, Mary Shariff, Leonie Herx, “L’Aide Médicale à Mourir et le sacrifice de la norme de qualité de soins de la pratique médicale » in Nathalie Vézina, Pascal Fréchette and Louise Bernier, Mélanges Robert P. Kouri – L’humain au cœur du droit (Yvons Blais : 2021) at 621-644.
Kanksha Mahadevia Ghimire & Trudo Lemmens, “Data Transparency and Rare Diseases: Privacy vs Public Interest” in Katherine Fierlbeck, Matthew Herder & Janice Graham, eds., Beyond Transparency (University of Toronto Press, 2021) at 184-218.
Trudo Lemmens & Kanksha Mahadevia Ghimire, “Regulation of the Health Professions in Ontario: Self-Regulation with Statutory-Based Public Accountability” (2019) 19(3) Journal of Health Law/Revista de Dereito Sanitario 124-204.
Trudo Lemmens & Carlos Herrera Vacaflor, “Research Transparency in the Americas: The Need to Coordinate Regulatory Spheres” (2018) 362 British Medical Journal k2493-8
“Charter Scrutiny of Canada's Medical Assistance in Dying Law and the Shifting Landscape of Belgian and Dutch Euthanasia Practice” (2018) 85 Supreme Court Law Review (2nd) 453-539.
Trudo Lemmens, Heesoo Kim & Elizabeth Kurz, “Why Canada’s Medical Assistance in Dying Law Should Be C(h)arter Compliant and What it May Help to Avoid” (2017) 11(1) McGill Journal of Law & Health S61-S148.
Scott Y.H. Kim & Trudo Lemmens, “Should assisted dying for psychiatric disorders be legalized in Canada? (2016) Canadian Medical Association Journal cmaj.160365; doi:10.1503/cmaj.160365
Louis Charland, Trudo Lemmens & Kyoko Wada, “Decision-Making Capacity to Consent for Medical Assistance in Dying for Persons with Mental Disorders” (2016) Open Issue Journal of Ethics in Mental Health 1-15
Trudo Lemmens & Shannon Gibson, "Decreasing the Data Deficit: Improving Post-Market Surveillance in Pharmaceutical Regulation" (2014) 59(4) McGill Law Journal 943-988.
Shannon Gibson & Trudo Lemmens, "Niche Markets and Evidence Assessment in Transition: A Critical Review of Proposed Drug Reforms" (2014) 22(2) Medical Law Review 200-220.
“Pharmaceutical Knowledge Governance: A Human Rights Perspective” (2013) 41(1) Journal of Law, Medicine and Ethics 163-84.
Trudo Lemmens & Candice Telfer, “Access to Data and the Right to Health: The Human Rights Case for Clinical Trials Transparency” (2012) 31(1) American Journal of Law & Medicine 63-112.
Simon Stern & Trudo Lemmens, “Legal Remedies for Medical Ghostwriting: Imposing Fraud Liability on Guest Authors of Ghostwritten Articles” (2011) 8(8) PLoS Medicine 1-8
Trudo Lemmens & Lisa Austin, “The End of Individual Control Over Health Information: Governing Biobanks and Promoting Fair Information Practices” in Jane Kaye & Mark Stranger, eds, Governing Biobanks (Farnham (UK): Ashgate, 2009) 243-266.